Sugi Predict

Sugi Predict / Compounds / SCHEMBL8249002

SCHEMBL8249002

SCHEMBL8249002

O=C1C2CC=CCC2C(=O)C2CC=CCC12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.39
▸ LMNA P02545 3/20 0.39
▸ TP53 P04637 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.38
▸ TDP1 Q9NUW8 3/20 0.37
▸ CA9 Q16790 4/20 0.34
▸ CA12 O43570 3/20 0.34
▸ CA1 P00915 3/20 0.34
▸ CA2 P00918 3/20 0.34
▸ POLB P06746 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11542394 0.76 TSHR (0.39) ALDH1A1LMNATSHRKMT2AHSD17B10
SCHEMBL8255299 0.76 CA12 (0.32) ALDH1A1LMNATP53TSHRKMT2A
SCHEMBL11546899 0.74 ALDH1A1 (0.48) ALDH1A1LMNATSHRKMT2AHSD17B10
SCHEMBL13528553 0.74 ALDH1A1 (0.48) ALDH1A1LMNATSHRKMT2AHSD17B10
SCHEMBL16607543 0.74 ALDH1A1 (0.47) ALDH1A1LMNATP53TSHRKMT2A
SCHEMBL17970089 0.74 ALDH1A1 (0.47) ALDH1A1LMNATP53TSHRKMT2A
SCHEMBL41953 0.74 ALDH1A1 (0.47) ALDH1A1LMNATP53TSHRKMT2A
SCHEMBL11283022 0.73 ALDH1A1 (0.37) ALDH1A1LMNATP53TSHRKMT2A
SCHEMBL1628615 0.73 ALDH1A1 (0.37) ALDH1A1LMNATP53TSHRKMT2A
SCHEMBL7123770 0.73 ALDH1A1 (0.37) ALDH1A1LMNATP53TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4764252-A DELIGNIFICATION OJI PAPER CO., LTD. (JP) 1988-08-16 — — US claimed
US-4473439-A QUINONE, HYDROQUINONE, OR DIKETO OR HYDROXYHYDROANTHRACENE ACCELERATING ADDITIVE OJI PAPER CO., LTD. (JP) 1984-09-25 — — US claimed
US-4363700-A Process for pulping lignocellulosic material with an alkaline sulfide cooking liquor containing an accelerating additive and reducing assistant OJI PAPER CO., LTD. (JP) 1982-12-14 — — US claimed
US-4036681-A Delignification of lignocellulosic material with an alkaline pulping liquor containing a Diels Alder adduct of benzoquinone or naphthoquinone CANADIAN INDUSTRIES, LTD. (CA) 1977-07-19 — — US claimed
US-4036680-A Delignification of lignocellulosic material with a soda pulping liquor containing a Diels Alder adduct of benzoquinone or naphthoquinone in admixture with a nitro aromatic compound CANADIAN INDUSTRIES, LTD. (CA) 1977-07-19 — — US claimed
EP-4115462-A1 BYPRODUCT FREE METHODS FOR SOLID HYBRID ELECTROLYTE Blue Current, Inc. (US) 2023-01-11 — — EP disclosed
US-20210313616-A1 BYPRODUCT FREE METHODS FOR SOLID HYBRID ELECTROLYTE Blue Current, Inc. 2021-10-07 — — US disclosed
US-20210313616-A1 BYPRODUCT FREE METHODS FOR SOLID HYBRID ELECTROLYTE Blue Current, Inc. 2021-10-07 — — US disclosed
US-8076330-B2 Dipeptidyl peptidase-IV inhibitors AMGEN INC. (US) 2011-12-13 — — US disclosed
US-8076330-B2 Dipeptidyl peptidase-IV inhibitors AMGEN INC. (US) 2011-12-13 — — US disclosed
US-20110112051-A1 Dipeptidyl Peptidase-IV Inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2011-05-12 — — US disclosed
US-20110112051-A1 Dipeptidyl Peptidase-IV Inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2011-05-12 — — US disclosed
EP-0010451-A1 Process for the delignification of lignocellulosic material and products thereof C.I.L. Inc. (CA) 1980-04-30 — — EP disclosed
EP-0006201-A1 Agent usable for the production of cellulose and process for the production of cellulose BAYER AG (DE) 1980-01-09 — — EP disclosed
EP-0004928-A1 Dispersion to be used in the production of cellulose and process for producing cellulose using this dispersion BAYER AG (DE) 1979-10-31 — — EP disclosed
US-4152340-A BY REACTING 1,4,4A,5,8,8A,9A,10A-OCTAHYDRO-ANTHRAQUINONE WITH NITROBENZENE, BASIC COMPOUND, INHIBITOR PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1979-05-01 — — US disclosed
US-4152340-A BY REACTING 1,4,4A,5,8,8A,9A,10A-OCTAHYDRO-ANTHRAQUINONE WITH NITROBENZENE, BASIC COMPOUND, INHIBITOR PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1979-05-01 — — US disclosed
US-4146559-A CHAIN EXTENDERS, CROSSLINKERS FOR POLYURETHANES, POLYUREAS BAYER AKTIENGESELLSCHAFT (DE) 1979-03-27 — — US disclosed
US-4113749-A CONDENSATION OF A HYDROANTHRAQUINONE BY HEATING IN ABSENCE OF OXYGEN KAWASAKI KASEI CHEMICALS LTD. (JP) 1978-09-12 — — US disclosed
US-4036681-A Delignification of lignocellulosic material with an alkaline pulping liquor containing a Diels Alder adduct of benzoquinone or naphthoquinone CANADIAN INDUSTRIES, LTD. (CA) 1977-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112051-A1 Dipeptidyl Peptidase-IV Inhibitors DPP4, DPP3, DPP7 ALDH1A1 1358/4885LMNA 4383/4885TP53 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.